Posted on 1/5/21
ADMA Biologics: A Perfect Storm
Summary ADMA has been overly chastised by the market, and its business is performing very well.At its current trading level, ADMA is trading at just about . . .
Posted on 1/5/21
Johnson & Johnson Declares Fresh Dividend; Yield Is 2.6%
The beginning of the year is full of signature events. For many income investors, Johnson & Johnson's (NYSE:JNJ) first dividend declaration is one of them -- . . .
Posted on 1/5/21
The Worst Mistake Moderna Investors Can Make Right Now
In late 2018, Moderna (NASDAQ: MRNA) went public in the largest biotech IPO in history. Its value barely moved until mid-February 2020, when COVID-19 cases in . . .
Posted on 1/5/21
Moderna Lifts Its Estimate for 2021 Coronavirus Vaccine Production by 20%
If all goes according to its revised plan, Moderna (NASDAQ:MRNA) will have far more doses of its coronavirus vaccine on the market than formerly anticipated. The . . .
Posted on 1/5/21
Maryland’s Average Positive Test Rate Climbs for Seventh Straight Day, Reaching Highest Point Since June
An average of 9.47% of Maryland’s coronavirus tests over the last seven days came back positive, marking the highest seven-day average positive test rate since June.The . . .
Posted on 1/4/21
Flowonix Medical and SWK Holdings Closes $33M Financing
Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty . . .
Posted on 1/4/21
Charles River Laboratories Acquires Distributed Bio
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination
Posted on 1/4/21
AzurRx BioPharma Offers $8.0 Million Series C Stock
DELRAY BEACH, Fla., Jan. 04, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal . . .
Posted on 1/4/21
Boston Scientific Corporation: Buy This Secular Grower As Elective Procedures Rebound
SummaryBoston Scientific Corporation has demonstrated strong growth under CEO Mike Mahoney and is projected to grow organically at the high end of its peer group.The stock . . .
Posted on 1/4/21
Novavax: The Moment Of Truth Arrives
SummaryNVAX recently announced it had initiated Phase 3 trials for a COVID-19 vaccine in the U.S.If NVAX wins FDA approval, then it could generate billions in . . .
Posted on 1/4/21
Dun & Bradstreet - Increasingly Appealing
Summary Dun & Bradstreet has seen solid momentum since going public this summer.The company has seen solid topline sales growth in the first two quarterly earnings . . .
Posted on 1/4/21
Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.
The gap between the first and booster doses of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine has been widened substantially in the U.K. -- and Pfizer . . .
Posted on 1/4/21
Pfizer's Next Multibillion-Dollar COVID Vaccine Move
Pfizer (NYSE:PFE) made one of the smartest decisions in the company's long history earlier this year. It chose to partner with German biotech BioNTech (NASDAQ:BNTX) on . . .
Posted on 1/4/21
Why Did Johnson & Johnson Cut the Size of Its Coronavirus Vaccine Trial?
Johnson & Johnson(NYSE:JNJ) is trailing the leaders in the coronavirus vaccine race, but the healthcare giant is approaching the finish line, thanks to cutting the size . . .
Posted on 1/4/21
Should Investors Be Worried About Pfizer and BioNTech's Coronavirus Vaccine Rollout?
In this video from Motley Fool Live, recorded on Dec. 21, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the . . .
Posted on 1/4/21
Why Teladoc Stock Soared 139% in 2020
What happenedShares of telehealth leader Teladoc Health (NYSE:TDOC) soared 139% in 2020, according to data from S&P Global Market Intelligence. That performance made it one of . . .
Posted on 1/4/21
Why Moderna Stock Fell 32% in December
What happenedShares of biotech Moderna (NASDAQ:MRNA), maker of a COVID-19 vaccine, dropped 31.6% in December, according to data from S&P Global Market Intelligence. For context, the . . .
Posted on 1/4/21
EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics
WATERTOWN, Mass., Jan. 03, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 1/3/21
Acorda Therapeutics Completes One-for-Six Reverse Stock Split
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the previously announced 1-for-6 reverse stock split of its outstanding and authorized shares . . .
Posted on 1/3/21
New Dermatology Company Resilia Pharmaceuticals Begins Operations
Peak Pharma Commercial Partners, a New York City-based investment fund dedicated to the acquisition and growth of branded, generic and over-the-counter pharmaceutical products (www.peakpharmapartners.com). announced today . . .
Posted on 1/3/21
BrainStorm Issues 2020 Letter to Shareholders
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the following letter from its Chief Executive Officer, Chaim . . .
Posted on 1/3/21
Maryland’s Average Positive Test Rate Continues to Grow
The seven-day average rate of positive coronavirus tests has remained above 8% for the second consecutive day after staying below that mark for 22 days before . . .
Posted on 1/3/21
Maryland Reports 63 Coronavirus Deaths, Highest Daily Death Total in Seven Months
Maryland officials on Tuesday reported 63 more deaths related to coronavirus, the second highest daily death total reported in the past seven months.The state reported a . . .
Posted on 1/3/21
KemPharm Announces 1-for-16 Reverse Stock Split
CELEBRATION, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today . . .
Posted on 12/29/20
Andrew Hanna Explains the Important Role of Community Pharmacies in Distributing COVID-19 Vaccines
COVID-19 has had a damaging and disruptive effect on the Canadian people and on the country’s healthcare system. As of December 21, 2020, over 14,000 Canadians . . .

